NCT06961825

Brief Summary

Brief Summary: The main objective of this thesis is to investigate the role of nutrition - specifically the administration of protein supplements (single dose and double dose) - in the rehabilitation of stroke patients with low albumin levels in relation to sarcopenia, osteopenia and functional recovery indices. The study will follow a randomized controlled trial design, incorporating clinical observation, analysis of biochemical markers, and assessment of physical and functional parameters. Participants will be randomly assigned to one of the three groups: (1) Group 1, receiving no protein supplementation (control group), (2) Group 2, receiving a single dose of protein supplement and (3) Group 3, receiving a double dose of protein supplement. The intervention will last for at least six weeks or until the biochemical markers of albumin normalize and the patient resumes regular oral intake. Biochemical assessment with be conducted through regular nutritional evaluations including measurement of serum albumin, prealbumin, C - reactive protein, creatinine, blood glucose and glycosylated hemoglobin (HbA1c), urea, electrolytes, urine albumin and additional inflammatory markers. Bone density will be assessed using DEXA, MBSR and hip measurements to determine the potential improvements resulting from the intervention. Muscle mass will be evaluated using whole - body DEXA analysis, while muscle strength and mobility will be assessed through grip strength tests and fine gait assessments. Functional recovery will be evaluated usings standardized tools for activities of daily living (Barthel Index), mental state (Geriatric Depression Scale) and quality of life (SF - 36), as well as mobility and walking tests such as the Timed Up and Go Test and 6 - Minute Walk Test. The collected data will be analyzed using appropriate statistical tools, including comparison models (ANOVA, Mann - Whitney U test) and correlation models (Pearson - Spearman). This research is expected to enhance theoretical knowledge regarding the relationship between nutrition, biochemical markers and rehabilitation outcomes in stroke patients with hypoalbuminemia. More specifically, it aims to explore the underlying mechanisms through which nutrition affects recovery - a field that remains unexplored. Additionally, the anticipated finding may contribute to the development of clinical guidelines and therapeutic approaches for the nutritional management of patients with low albumin levels, promoting personalized nutritional strategies that support effective post - stroke rehabilitation.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for not_applicable stroke

Timeline
49mo left

Started May 2025

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
May 2025May 2030

First Submitted

Initial submission to the registry

April 29, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

May 5, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2025

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2030

Last Updated

May 8, 2025

Status Verified

April 1, 2025

Enrollment Period

5 years

First QC Date

April 29, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

protein supplementationnutritional interventionalbumin levelsstrokestroke rehabilitationeating disordersmalnutritionnutritional assessmentsarcopeniaosteopenia

Outcome Measures

Primary Outcomes (1)

  • Serum Albumin Levels

    Change in serum albumin concentration to assess nutritional status and response to protein supplementation.

    Baseline and every 2 weeks for up to 6 weeks

Secondary Outcomes (1)

  • Muscle Mass (Whole-body DEXA)

    Baseline and at week 6

Study Arms (3)

Protein Supplement - Single Dose

EXPERIMENTAL

Participants in this arm will receive one dose of protein supplement daily.

Dietary Supplement: Dietary Supplement

Protein Supplement - Double Dose

EXPERIMENTAL

Participants in this arm will receive two doses of protein supplement daily.

Dietary Supplement: Dietary Supplement

Control group

NO INTERVENTION

no protein supplementation

Interventions

Dietary SupplementDIETARY_SUPPLEMENT

complete, semi-elemental formula for tube feeding and orla intake based on peptides, in powder form, low in fat (32% of energy), high in MCTs (\>90% of total fat) free of fiber and gluten

Protein Supplement - Double DoseProtein Supplement - Single Dose

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age range: Adults aged 18 to 85 years
  • Diagnosis: Patients diagnosed with a stroke (cerebrovascular accident) within the last 4 to 6 weeks
  • Serum albumin levels: Patients with low serum albumin levels (\< 3.5 g / dL)
  • Nutritional intervention requirement: Patients who require nutritional intervention to support rehabilitation and nutrition
  • Informed consent: Patients who have completed the consent form for participation in the study and acceptance of the intervention

You may not qualify if:

  • Severe infections or serious cardiopulmonary conditions: Patients with severe infections or serious cardiopulmonary conditions requiring immediate medical intervention, which may affect nutrition and rehabilitation
  • Comorbidities: Patients with comorbid conditions such as renal or liver disease
  • History of stroke or neurological conditions: Patients with a history of stroke or other neurological conditions who do not meet the criteria for rehabilitation
  • Severe mental or psychological conditions: Patients with severe mental or psychological conditions who are unable to understand or consent to participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Ioannina

Ioannina, Greece, 4500, Greece

Location

MeSH Terms

Conditions

StrokeHypoalbuminemiaSarcopeniaBone Diseases, MetabolicMalnutritionProtein-Energy MalnutritionFeeding and Eating Disorders

Interventions

Dietary Supplements

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHypoproteinemiaBlood Protein DisordersHematologic DiseasesHemic and Lymphatic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesNutrition DisordersProtein DeficiencyDeficiency DiseasesSigns and Symptoms, DigestiveMental Disorders

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Avraam Ploumis

    University Hospital, Ioannina

    PRINCIPAL INVESTIGATOR

Central Study Contacts

ΑΒΡΑΑΜ Πλούμης

CONTACT

Avraam Ploumis

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Single (Outcomes Assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistan Professor of PMR,Orthopaedic Spine Surgeon

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 8, 2025

Study Start

May 5, 2025

Primary Completion (Estimated)

May 5, 2030

Study Completion (Estimated)

May 5, 2030

Last Updated

May 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations